Analysts’ ratings reiterations for Monday, January 13th: Alnylam Pharmaceuticals (NASDAQ:ALNY) had its market perform rating reissued by analysts at JMP Securities. The analysts wrote, “Development of ALNY RNAi therapeutic candidates is progressing ahead of prior guidance; reiterate Market Outperform rating and $68 price target on Alnylam. Last Friday, ALNY announced key pipeline goals for 2014, […]
Analysts’ Ratings Reiterations for January, 13th (ALNY, BARC, BCRX, BOY, BRBY, CPI, EDR, GKN, GMCR, HMSO) is a post from: Zolmax
The post Analysts’ Ratings Reiterations for January, 13th (ALNY, BARC, BCRX, BOY, BRBY, CPI, EDR, GKN, GMCR, HMSO) appeared first on Zolmax.